RIO DE JANEIRO, BRAZIL - On Friday, July 17th South Korea became the first country to approve human trials of an antibody-based medication against the novel . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here